The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data
Open accessAbstract
Chronic kidney disease (CKD) is a worldwide public health problem that affects millions of people from all racial and ethnic groups. At end of 2013, over 300,000 Japanese patients had maintenance dialysis therapy (JSDT). In Japan, the major causes of end stage kidney disease (ESKD) are chronic glomerulonephritis (particularly IgA nephropathy), type 2 diabetic nephropathy, and hypertensive nephrosclerosis. Hypertension is a major factor driving the progression of CKD to ESKD. Since many features of the pathogenesis of IgA nephropathy are still obscure, specific treatment is not yet available. However, efforts by investigators around the world have gradually clarified different aspects of the pathogenesis and treatment of IgA nephropathy. Today, around half of all diabetic patients in Japan receive medical treatment. Type 2 diabetic nephropathy is one of the major long-term microvascular complications occurring in nearly 40% of Japanese diabetic patients. The pathogenesis of diabetic nephropathy involves both genetic and environmental factors. However, the candidate genes related to the initiation and progression of the disorder are still obscure in patients with diabetic nephropathy. Regarding environmental factors, the toxicity of persistent hyperglycemia, reactive oxygen species, systemic and/or glomerular hypertension, dyslipidemia and complement are considered to play an important role. The first part of this review covers the pathogenesis of IgA nephropathy and type 2 diabetic nephropathy, and combines the clinicopathological findings in patients with our research on the ddY and KKA-y mouse models (spontaneous animal models for IgA nephropathy and diabetic nephropathy, respectively). In Japan, the major renal replacement therapies (RRT) are peritoneal dialysis (PD) and hemodialysis (HD). The second part of this review focuses on PD and HD. Based on our research findings from patients and as well as from animal models, we discuss strategies for the management of patients on PD and HD. i 2015 S. Karger AG, Basel
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran, D. C., Coppo, R., Cook, H. T., Feehally, J., Roberts, I. S. D., Troyanov, S., Alpers, C. E., Amore, A., Barratt, J., et al. (2009) · Kidney International · doi:10.1038/ki.2009.243 · Cited by 1,235
Self-citationCombined angiotensin inhibition for the treatment of diabetic nephropathy
Fried, L. F., Emanuele, N., Zhang, J. H., Brophy, M., Conner, T. A., Duckworth, W., Leehey, D. J., McCullough, P. A., O'Connor, T., Palevsky, P. M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303154 · Cited by 1,169
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
Parving, H.-H., Persson, F., Lewis, J. B., Lewis, E. J., & Hollenberg, N. K. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708379 · Cited by 1,098
Morphologic Changes in the Peritoneal Membrane of Patients with Renal Disease
Williams, J. D., Craig, K. J., Topley, N., Von Ruhland, C., Fallon, M., Newman, G. R., Mackenzie, R. K., & Williams, G. T. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v132470 · Cited by 959
[Intercapillary deposits of IgA-IgG].
Berger, J., & Hinglais, N. (1968) · PubMed · Cited by 800
Donadio, J. V., & Grande, J. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020109 · Cited by 661
The structure and function of human IgA
Kerr, M. A. (1990) · Biochemical Journal · doi:10.1042/bj2710285 · Cited by 596
Tomana, M., Novak, J., Julian, B. A., Matousovic, K., Konecny, K., & Mestecky, J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5535 · Cited by 498
Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes
Niewczas, M. A., Gohda, T., Skupien, J., Smiles, A. M., Walker, W. H., Rosetti, F., Cullere, X., Eckfeldt, J. H., Doria, A., Mayadas, T. N., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060627 · Cited by 485
Research works printed but not linked: 60
- 10.1002/jcla.20227 · doi:10.1002/jcla.20227
- 10.5301/jn.5000151 · doi:10.5301/jn.5000151
- 10.1002/jcla.20154 · doi:10.1002/jcla.20154
- 10.5301/jn.5000278 · doi:10.5301/jn.5000278
- 10.1093/ndt/gfs262 · doi:10.1093/ndt/gfs262
- 10.1007/s00795-011-0538-3 · doi:10.1007/s00795-011-0538-3
- 10.1159/000054214 · doi:10.1159/000054214
- 10.1093/ndt/gfs500 · doi:10.1093/ndt/gfs500
- 10.1007/s00011-007-6145-z · doi:10.1007/s00011-007-6145-z
- 10.1038/ki.1985.76 · doi:10.1038/ki.1985.76
- 10.1681/ASN.2004030219 · doi:10.1681/asn.2004030219
- 10.1159/000046067 · doi:10.1159/000046067
- 10.1159/000044994 · doi:10.1159/000044994
- 10.1016/S0272-6386(12)80272-1 · doi:10.1016/s0272-6386(12)80272-1
- 10.1046/j.1523-1755.1999.00750.x · doi:10.1046/j.1523-1755.1999.00750.x
- 10.4049/jimmunol.180.2.1008 · doi:10.4049/jimmunol.180.2.1008
- 10.1111/j.1365-2249.2006.03026.x · doi:10.1111/j.1365-2249.2006.03026.x
- 10.1038/sj.ki.5000074 · doi:10.1038/sj.ki.5000074
- 10.1159/000187984 · doi:10.1159/000187984
- 10.1002/jcla.10071 · doi:10.1002/jcla.10071
- 10.1002/(SICI)1098-2825(1998)12:1<1::AID-JCLA1>3.0.CO;2-F · DOI
- 10.1159/000168359 · doi:10.1159/000168359
- 10.1093/ndtplus/sfp014 · doi:10.1093/ndtplus/sfp014
- 10.1007/s10157-009-0179-1 · doi:10.1007/s10157-009-0179-1
- 10.1093/ndt/gfr403 · doi:10.1093/ndt/gfr403
- 10.1016/j.cca.2012.02.029 · doi:10.1016/j.cca.2012.02.029
- 10.1002/jcla.21608 · doi:10.1002/jcla.21608
- 10.1002/(SICI)1098-2825(1998)12:6<378::AID-JCLA8>3.0.CO;2-J · doi:10.1002/(sici)1098-2825(1998)12:6<378::aid-jcla8>3.0.co;2-j
- 10.1002/jcla.1026 · doi:10.1002/jcla.1026
- 10.1159/000064453 · doi:10.1159/000064453
- 10.1002/1098-2825(2001)15:1<25::AID-JCLA5>3.0.CO;2-Y · doi:10.1002/1098-2825(2001)15:1<25::aid-jcla5>3.0.co;2-y
- 10.1093/ndt/14.suppl_3.1 · doi:10.1093/ndt/14.suppl_3.1
- 10.1590/S0102-86502007000500003 · doi:10.1590/s0102-86502007000500003
- 10.4236/jdm.2012.23054 · doi:10.4236/jdm.2012.23054
- 10.1155/2012/702948 · DOI
- 10.1159/000049428 · doi:10.1159/000049428
- 10.1159/000100498 · DOI
- 10.1016/j.metabol.2008.01.007 · doi:10.1016/j.metabol.2008.01.007
- 10.5551/jat.3764 · DOI
- 10.1111/j.1463-1326.2012.01566.x · doi:10.1111/j.1463-1326.2012.01566.x
- 10.1155/2013/519130 · doi:10.1155/2013/519130
- 10.1002/jcla.20027 · doi:10.1002/jcla.20027
- 10.1007/s10047-012-0663-3 · doi:10.1007/s10047-012-0663-3
- 10.1159/000183987 · doi:10.1159/000183987
- 10.1159/000169582 · doi:10.1159/000169582
- 10.2215/CJN.03630807 · doi:10.2215/cjn.03630807
- 10.1093/ndt/gfq194 · doi:10.1093/ndt/gfq194
- 10.5414/CNP69121 · doi:10.5414/cnp69121
- 10.1007/s10047-013-0741-1 · doi:10.1007/s10047-013-0741-1
- 10.1093/ndt/17.7.1293 · doi:10.1093/ndt/17.7.1293
- 10.1371/journal.pone.0053382 · doi:10.1371/journal.pone.0053382
- 10.1093/ndt/gfm323 · doi:10.1093/ndt/gfm323
- 10.1111/j.1744-9987.2011.00936.x · doi:10.1111/j.1744-9987.2011.00936.x
- 10.1016/j.molimm.2004.12.006 · doi:10.1016/j.molimm.2004.12.006
- 10.1016/j.molimm.2005.06.018 · doi:10.1016/j.molimm.2005.06.018
- 10.1111/j.1365-2249.2004.02634.x · doi:10.1111/j.1365-2249.2004.02634.x
- 10.2147/IJNRD.S65929 · doi:10.2147/ijnrd.s65929
- 10.1159/000073442 · doi:10.1159/000073442
- 10.1177/000331970005100206 · doi:10.1177/000331970005100206
- 10.1097/00004872-199107000-00003 · doi:10.1097/00004872-199107000-00003
Cited by
Hartleben, B., Gödel, M., Meyer-Schwesinger, C., Liu, S., Ulrich, T., Köbler, S., Wiech, T., Grahammer, F., Arnold, S. J., Lindenmeyer, M. T., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39492 · Cited by 721
Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome
Mihai, S., Codrici, E., Popescu, I. D., Enciu, A.-M., Albulescu, L., Necula, L. G., Mambet, C., Anton, G., & Tanase, C. (2018) · Journal of Immunology Research · doi:10.1155/2018/2180373 · Cited by 673
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub3 · Cited by 630
Diabetic nephropathy – complications and treatment
Lim, A. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s40172 · Cited by 583
mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
Inoki, K., Mori, H., Wang, J., Suzuki, T., Hong, S., Yoshida, S., Blattner, S. M., Ikenoue, T., Rüegg, M. A., Hall, M. N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44771 · Cited by 538
Role of Inflammation in Muscle Homeostasis and Myogenesis
Costamagna, D., Costelli, P., Sampaolesi, M., & Penna, F. (2015) · Mediators of Inflammation · doi:10.1155/2015/805172 · Cited by 534
Qi, W., Keenan, H. A., Li, Q., Ishikado, A., Kannt, A., Sadowski, T., Yorek, M. A., Wu, I.-H., Lockhart, S., Coppey, L. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4328 · Cited by 479
Heerspink, H. J. L., Perco, P., Mulder, S., Leierer, J., Hansen, M. K., Heinzel, A., & Mayer, G. (2019) · Diabetologia · doi:10.1007/s00125-019-4859-4 · Cited by 457
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub4 · Cited by 405
Advanced Glycation end Products, Oxidative Stress and Diabetic Nephropathy
Yamagishi, S.-I., & Matsui, T. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.2.11148 · Cited by 397
The Tn Antigen—Structural Simplicity and Biological Complexity
Ju, T., Otto, V. I., & Cummings, R. D. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201002313 · Cited by 363
Trajectories of kidney function in diabetes: a clinicopathological update
Oshima, M., Shimizu, M., Yamanouchi, M., Toyama, T., Hara, A., Furuichi, K., & Wada, T. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00462-y · Cited by 346
Urinary excretion of viable podocytes in health and renal disease
Vogelmann, S. U., Nelson, W. J., Myers, B. D., & Lemley, K. V. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00404.2002 · Cited by 335
Diagnosis of diabetic kidney disease: state of the art and future perspective
Persson, F., & Rossing, P. (2018) · Kidney International Supplements · doi:10.1016/j.kisu.2017.10.003 · Cited by 335
Exosomal proteins as potential diagnostic markers in advanced non‐small cell lung carcinoma
Jakobsen, K. R., Paulsen, B. S., Bæk, R., Varming, K., Sorensen, B. S., & Jørgensen, M. M. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.26659 · Cited by 333
Japanese Clinical Practice Guideline for Diabetes 2016
Haneda, M., Noda, M., Origasa, H., Noto, H., Yabe, D., Fujita, Y., Goto, A., Kondo, T., & Araki, E. (2018) · Diabetology International · doi:10.1007/s13340-018-0345-3 · Cited by 319
New developments in the genetics, pathogenesis, and therapy of IgA nephropathy
Magistroni, R., D’Agati, V. D., Appel, G. B., & Kiryluk, K. (2015) · Kidney International · doi:10.1038/ki.2015.252 · Cited by 302
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., Summerbell, C. D., Worthington, H. V., Song, F., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub5 · Cited by 295
Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus
Hartweg, J., Perera, R., Montori, V. M., Dinneen, S. F., Neil, A. H., & Farmer, A. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003205.pub2 · Cited by 282
Tuttle, K. R., Brosius, F. C., Adler, S. G., Kretzler, M., Mehta, R. L., Tumlin, J. A., Tanaka, Y., Haneda, M., Liu, J., Silk, M. E., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx377 · Cited by 284
The next generation of therapeutics for chronic kidney disease
Breyer, M. D., & Susztak, K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.67 · Cited by 272
Biomarkers of diabetic kidney disease
Colhoun, H. M., & Marcovecchio, M. L. (2018) · Diabetologia · doi:10.1007/s00125-018-4567-5 · Cited by 270
Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis
Tziomalos, K., & Athyros, V. G. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.110 · Cited by 268
Omega 3 fatty acids for prevention and treatment of cardiovascular disease
Hooper, L., Harrison, R. A., Summerbell, C. D., Moore, H., Worthington, H. V., Ness, A., Capps, N., Davey Smith, G., Riemersma, R., & Ebrahim, S. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub2 · Cited by 264
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
Jung, C.-Y., & Yoo, T.-H. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0329 · Cited by 262
Emerging role of autophagy in kidney function, diseases and aging
Huber, T. B., Edelstein, C. L., Hartleben, B., Inoki, K., Jiang, M., Koya, D., Kume, S., Lieberthal, W., Pallet, N., Quiroga, A., et al. (2012) · Autophagy · doi:10.4161/auto.19821 · Cited by 253
Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
Matoba, K., Takeda, Y., Nagai, Y., Kawanami, D., Utsunomiya, K., & Nishimura, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143393 · Cited by 223
Wang, T., Zhang, X., Zhou, N., Shen, Y., Li, B., Chen, B. E., & Li, X. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029512 · Cited by 73
Metadata
- Authors
- Tomino, Y.
- Venue
- Kidney and Blood Pressure Research
- Publisher
- S. Karger AG
- Published
- 2014
- Volume
- 39
- Issue
- 5
- Pages
- 450-489
- ISSN
- 1420-4096 (ISSN-L)
- 1423-0143
- OpenAlex
- W2029774820
- Cited by
- 566
- References
- 90
- FWCI
- 44.43
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by-nc/3.0/ (vor)
- creativecommons.org/licenses/by-nc/3.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.